Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland

Detalles Bibliográficos
Autores principales: Ahava, Maarit J., Jarva, Hanna, Jääskeläinen, Anne J., Lappalainen, Maija, Vapalahti, Olli, Kurkela, Satu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049924/
https://www.ncbi.nlm.nih.gov/pubmed/35484359
http://dx.doi.org/10.1007/s10096-022-04448-x
_version_ 1784696250324484096
author Ahava, Maarit J.
Jarva, Hanna
Jääskeläinen, Anne J.
Lappalainen, Maija
Vapalahti, Olli
Kurkela, Satu
author_facet Ahava, Maarit J.
Jarva, Hanna
Jääskeläinen, Anne J.
Lappalainen, Maija
Vapalahti, Olli
Kurkela, Satu
author_sort Ahava, Maarit J.
collection PubMed
description
format Online
Article
Text
id pubmed-9049924
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-90499242022-04-29 Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland Ahava, Maarit J. Jarva, Hanna Jääskeläinen, Anne J. Lappalainen, Maija Vapalahti, Olli Kurkela, Satu Eur J Clin Microbiol Infect Dis Letter to the Editor Springer Berlin Heidelberg 2022-04-28 2022 /pmc/articles/PMC9049924/ /pubmed/35484359 http://dx.doi.org/10.1007/s10096-022-04448-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Ahava, Maarit J.
Jarva, Hanna
Jääskeläinen, Anne J.
Lappalainen, Maija
Vapalahti, Olli
Kurkela, Satu
Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
title Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
title_full Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
title_fullStr Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
title_full_unstemmed Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
title_short Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
title_sort rapid increase in sars-cov-2 seroprevalence during the emergence of omicron variant, finland
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049924/
https://www.ncbi.nlm.nih.gov/pubmed/35484359
http://dx.doi.org/10.1007/s10096-022-04448-x
work_keys_str_mv AT ahavamaaritj rapidincreaseinsarscov2seroprevalenceduringtheemergenceofomicronvariantfinland
AT jarvahanna rapidincreaseinsarscov2seroprevalenceduringtheemergenceofomicronvariantfinland
AT jaaskelainenannej rapidincreaseinsarscov2seroprevalenceduringtheemergenceofomicronvariantfinland
AT lappalainenmaija rapidincreaseinsarscov2seroprevalenceduringtheemergenceofomicronvariantfinland
AT vapalahtiolli rapidincreaseinsarscov2seroprevalenceduringtheemergenceofomicronvariantfinland
AT kurkelasatu rapidincreaseinsarscov2seroprevalenceduringtheemergenceofomicronvariantfinland

Ejemplares similares